you are viewing a single comment's thread.
The sad thing is that they don't have enough money or projected cashflow to bring this to market. Which is why they have emphasized that they are only focusing on VX-135 and the CF franchise.
if it works, they'll get the money from someone or somewhere. also a buyout can happen if they find one or more new drugs.
Sentiment: Strong Buy